These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use of quantitative fetal fibronectin for the prediction of preterm birth in women with exposed fetal membranes undergoing emergency cervical cerclage. Suff N; Hall M; Shennan A; Chandiramani M Eur J Obstet Gynecol Reprod Biol; 2020 Mar; 246():19-22. PubMed ID: 31923878 [TBL] [Abstract][Full Text] [Related]
3. The effect of blood staining on cervicovaginal quantitative fetal fibronectin concentration and prediction of spontaneous preterm birth. Hezelgrave NL; Kuhrt K; Cottam K; Seed PT; Tribe RM; Shennan AH Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():103-108. PubMed ID: 27918947 [TBL] [Abstract][Full Text] [Related]
4. Quantitative fetal fibronectin and cervical length to predict preterm birth in asymptomatic women with previous cervical surgery. Vandermolen BI; Hezelgrave NL; Smout EM; Abbott DS; Seed PT; Shennan AH Am J Obstet Gynecol; 2016 Oct; 215(4):480.e1-480.e10. PubMed ID: 27267388 [TBL] [Abstract][Full Text] [Related]
5. Mid-gestational changes in cervicovaginal fluid cytokine levels in asymptomatic pregnant women are predictive markers of inflammation-associated spontaneous preterm birth. Amabebe E; Chapman DR; Stern VL; Stafford G; Anumba DOC J Reprod Immunol; 2018 Apr; 126():1-10. PubMed ID: 29367099 [TBL] [Abstract][Full Text] [Related]
6. Predicting spontaneous preterm birth in asymptomatic high-risk women with cervical cerclage. Ridout AE; Ross G; Seed PT; Hezelgrave NL; Tribe RM; Shennan AH Ultrasound Obstet Gynecol; 2023 May; 61(5):617-623. PubMed ID: 36647576 [TBL] [Abstract][Full Text] [Related]
7. Blind vaginal fetal fibronectin swab for prediction of preterm birth. Farag AH; Mohammed MM; Ellaithy MI; Salama HA J Obstet Gynaecol Res; 2015 Jul; 41(7):1009-17. PubMed ID: 25771777 [TBL] [Abstract][Full Text] [Related]
9. Cervical length and quantitative fetal fibronectin in the prediction of spontaneous preterm birth in asymptomatic women with congenital uterine anomaly. Ridout AE; Ibeto LA; Ross GN; Cook JR; Sykes L; David AL; Seed PT; Tribe RM; Bennett PR; Terzidou V; Shennan AH; Chandiramani M; ; Brown RG; Chatfield S; Sadeh D Am J Obstet Gynecol; 2019 Oct; 221(4):341.e1-341.e9. PubMed ID: 31132343 [TBL] [Abstract][Full Text] [Related]
10. A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study. Stock SJ; Horne M; Bruijn M; White H; Heggie R; Wotherspoon L; Boyd K; Aucott L; Morris RK; Dorling J; Jackson L; Chandiramani M; David A; Khalil A; Shennan A; Baaren GV; Hodgetts-Morton V; Lavender T; Schuit E; Harper-Clarke S; Mol B; Riley RD; Norman J; Norrie J Health Technol Assess; 2021 Sep; 25(52):1-168. PubMed ID: 34498576 [TBL] [Abstract][Full Text] [Related]
11. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study. Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753 [TBL] [Abstract][Full Text] [Related]
12. A prospective, double-blinded cohort study using quantitative fetal fibronectin testing in symptomatic women for the prediction of spontaneous preterm delivery. Ng VWY; Seto MTY; Lewis H; Cheung KW BMC Pregnancy Childbirth; 2023 Apr; 23(1):225. PubMed ID: 37016314 [TBL] [Abstract][Full Text] [Related]
13. Quantitative fetal fibronectin to predict preterm birth in asymptomatic women at high risk. Abbott DS; Hezelgrave NL; Seed PT; Norman JE; David AL; Bennett PR; Girling JC; Chandirimani M; Stock SJ; Carter J; Cate R; Kurtzman J; Tribe RM; Shennan AH Obstet Gynecol; 2015 May; 125(5):1168-1176. PubMed ID: 25932845 [TBL] [Abstract][Full Text] [Related]
14. Cervicovaginal fetal fibronectin (FFN) for prediction of preterm delivery in symptomatic cases: a prospective study. Tanir HM; Sener T; Yildiz Z Clin Exp Obstet Gynecol; 2008; 35(1):61-4. PubMed ID: 18390084 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of additive effect of quantitative fetal fibronectin to cervical length for prediction of spontaneous preterm birth among asymptomatic low-risk women. Jwala S; Tran TL; Terenna C; McGregor A; Andrel J; Leiby BE; Baxter JK; Berghella V Acta Obstet Gynecol Scand; 2016 Aug; 95(8):948-55. PubMed ID: 27100022 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women. Jun SY; Lee JY; Kim HM; Kim MJ; Cha HH; Seong WJ BMC Pregnancy Childbirth; 2019 Jul; 19(1):241. PubMed ID: 31296172 [TBL] [Abstract][Full Text] [Related]
17. Fetal fibronectin testing in patients with short cervix in the midtrimester: can it identify optimal candidates for ultrasound-indicated cerclage? Keeler SM; Roman AS; Coletta JM; Kiefer DG; Feuerman M; Rust OA Am J Obstet Gynecol; 2009 Feb; 200(2):158.e1-6. PubMed ID: 19070833 [TBL] [Abstract][Full Text] [Related]
18. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis. Deshpande SN; van Asselt AD; Tomini F; Armstrong N; Allen A; Noake C; Khan K; Severens JL; Kleijnen J; Westwood ME Health Technol Assess; 2013 Sep; 17(40):1-138. PubMed ID: 24060096 [TBL] [Abstract][Full Text] [Related]
19. Contingent use of fetal fibronectin testing and cervical length measurement in women with preterm labour. Audibert F; Fortin S; Delvin E; Djemli A; Brunet S; Dubé J; Fraser WD J Obstet Gynaecol Can; 2010 Apr; 32(4):307-12. PubMed ID: 20500936 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of a risk prediction model of preterm birth for women with preterm labour symptoms (the QUIDS study): A prospective cohort study and individual participant data meta-analysis. Stock SJ; Horne M; Bruijn M; White H; Boyd KA; Heggie R; Wotherspoon L; Aucott L; Morris RK; Dorling J; Jackson L; Chandiramani M; David AL; Khalil A; Shennan A; van Baaren GJ; Hodgetts-Morton V; Lavender T; Schuit E; Harper-Clarke S; Mol BW; Riley RD; Norman JE; Norrie J PLoS Med; 2021 Jul; 18(7):e1003686. PubMed ID: 34228732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]